We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.59%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$169M
AUM Growth
-$13M
(-7.2%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-10.58%
Top 10 Holdings %
Top 10 Hldgs %
6.26%
Holding
495
New
55
Increased
122
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$947K |
| 2 |
Moderna
MRNA
|
+$899K |
| 3 |
Meta Platforms (Facebook)
META
|
+$895K |
| 4 |
Netflix
NFLX
|
+$876K |
| 5 |
Chipotle Mexican Grill
CMG
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.01M |
| 2 |
Progressive
PGR
|
+$999K |
| 3 |
Stryker
SYK
|
+$984K |
| 4 |
Republic Services
RSG
|
+$973K |
| 5 |
Linde
LIN
|
+$966K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.98% |
| 2 | Technology | 15.96% |
| 3 | Financials | 11.34% |
| 4 | Energy | 8.43% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
New Mountain Finance
NMFC
$646M
| $331K | 0.2% |
26,569
-3,696
| -12% | -$44.6K |
|
177
Oaktree Specialty Lending
OCSL
$1.03B
| $330K | 0.2% |
16,969
+10,619
| +167% | +$200K |
|
178
Alnylam Pharmaceuticals
ALNY
$36.3B
| $329K | 0.19% |
1,731
+414
| +31% | +$82.1K |
|
179
Biogen
BIIB
$29.9B
| $326K | 0.19% |
1,145
+81
| +8% | +$24.1K |
|
180
ADMA Biologics
ADMA
$1.92B
| $326K | 0.19% |
88,335
+4,410
| +5% | +$16.3K |
|
181
PTC Therapeutics
PTCT
$6.37B
| $325K | 0.19% |
7,989
+205
| +3% | +$10K |
|
|
FOLD
182
DELISTED
Amicus Therapeutics
FOLD
| $325K | 0.19% |
25,836
+1,097
| +4% | +$13K |
|
|
PNNT
183
Pennant Park Investment Corp
PNNT
$215M
| $324K | 0.19% |
54,975
+36,832
| +203% | +$199K |
|
|
TSVT
184
DELISTED
2seventy bio
TSVT
| $323K | 0.19% |
31,965
+6,923
| +28% | +$73.3K |
|
|
PHD
185
DELISTED
Pioneer Floating Rate Fund
PHD
| $321K | 0.19% |
36,927
-802
| -2% | -$6.88K |
|
186
Rhythm Pharmaceuticals
RYTM
$7B
| $320K | 0.19% |
19,414
+9,010
| +87% | +$163K |
|
187
Ligand Pharmaceuticals
LGND
$6.02B
| $318K | 0.19% |
4,405
-399
| -8% | -$29.9K |
|
188
Ultragenyx Pharmaceutical
RARE
$2.65B
| $316K | 0.19% |
6,860
+83
| +1% | +$3.85K |
|
|
NSL
189
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $316K | 0.19% |
69,073
-5,485
| -7% | -$25K |
|
|
ICPT
190
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $316K | 0.19% |
28,540
+7,922
| +38% | +$110K |
|
191
BioMarin Pharmaceuticals
BMRN
$11.5B
| $316K | 0.19% |
3,640
+801
| +28% | +$75.4K |
|
192
Lexicon Pharmaceuticals
LXRX
$1.02B
| $315K | 0.19% |
+137,450
| New | +$365K |
|
193
Mirum Pharmaceuticals
MIRM
$6.89B
| $314K | 0.19% |
12,129
-4,960
| -29% | -$132K |
|
194
Sixth Street Specialty
TSLX
$1.59B
| $313K | 0.19% |
16,728
-11,461
| -41% | -$209K |
|
195
Travere Therapeutics
TVTX
$5.33B
| $312K | 0.18% |
20,309
+3,635
| +22% | +$66.1K |
|
|
BTX
196
BlackRock Technology and Private Equity Term Trust
BTX
$957M
| $312K | 0.18% |
39,724
-6,373
| -14% | -$48.2K |
|
197
Petrobras
PBR
$121B
| $311K | 0.18% |
22,514
-6,071
| -21% | -$73.9K |
|
|
JRO
198
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $311K | 0.18% |
39,840
-1,278
| -3% | -$9.94K |
|
|
ELP
199
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $311K | 0.18% |
45,098
-6,802
| -13% | -$41.4K |
|
200
Enanta Pharmaceuticals
ENTA
$372M
| $309K | 0.18% |
14,438
+7,514
| +109% | +$222K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
ALS
Virtus ETF Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, Virtus ETF Advisers held 495 positions worth $169M, down 7.2% from $182M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Virtus ETF Advisers withdrew a net $17.8M in Q2 2023, closing 60 positions and reducing 257 holdings. Its most notable exit was Activision Blizzard, an estimated $1.01M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Virtus ETF Advisers opened a new position in NVIDIA worth $1.21M.
- Virtus ETF Advisers's largest Q2 2023 buy was NVIDIA: 28,520 shares worth $1.21M.
- Virtus ETF Advisers added most to Moderna in Q2 2023, an estimated $899K increase.
- Virtus ETF Advisers's biggest Q2 2023 reduction was Dow Inc, cutting an estimated $898K.
- Virtus ETF Advisers fully exited Activision Blizzard in Q2 2023, selling an estimated $1.01M.
- Virtus ETF Advisers's ten largest holdings make up 6.3% of its $169M portfolio in Q2 2023.
- Virtus ETF Advisers opened 55 new positions and closed 60 in Q2 2023.
- Virtus ETF Advisers's portfolio value fell 7.2% quarter-over-quarter to $169M.
Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.